trial · primary record
Dupilumab
Atopic Dermatitis
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2026-08-18 |
| Primary endpoint | Percent change from baseline in Eczema Area and Severity Index (EASI) score |
| Registry ID | NCT07330934 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:49.227Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07330934
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.